To test whether COX-2 appears to be cleaved in vivo, we tested its expression using an antibody directed at the C-terminus of the protein (amino acids 580–599) in a mouse model of malignant glioma [20] and in tumors of patients diagnosed with colorectal adenocarcinoma. This evidence concerns the gene PTGS2 and colorectal adenocarcinoma.